Professor Andy Scarsbrook
Consultant Radiologist and Nuclear Medicine Physician, Leeds Teaching Hospitals NHS Trust
About this event
- Date and time Mon 20 Mar 2023 from 9:45am to 4:30pm
- Location Online
- Organised by Radiology
Join us for our upcoming meeting, where we’ll be covering a broad range of topics related to PET-CT, with the aim of improving the care of those who require PET-CT scanning. We will look at novel and emerging technologies, how PET-CT scans can be used for various diseases, and the future of PET-CT delivery.
By attending, you will:
- Learn the best practices in the clinical use of PET-CT scans
- Learn about novel tracers entering the UK market and their uses, including antibody PET
- Explore the pitfalls that can occur on PET-CT scans in people with complex clinical problems and modern cancer treatments
- Gain a clear understanding of the role of PET-CT in non-cancerous diseases
- Learn how PET is used in different countries
- Appreciate the roles of integrated care boards and specialised services in the future of PET-CT delivery in the NHS
- Understand how AI could impact PET-CT reporting
This webinar is available for on-demand viewing. The webinar recording will be available for registered event participants up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Advanced Accelerator Applications, Blue Earth Diagnostics and Siemens Healthineers for their support of this meeting. Please note that the scientific programme and content has not been influenced in any way by the sponsors.
Key speakers
Professor Roland Hustinx
Professor of Nuclear Medicine, Liege University Hospital
Professor Gary Cook
Professor of PET imaging, King’s College London
Professor Rodney Hicks
Professor of Nuclear Medicine, Founder and Chief Medical Officer, Precision Molecular Imaging and Theranostics
Agenda
Day 1
Welcome and introduction
Session 1: PET-CT and new technologies
Chair: Dr Wai Lup Wong, Consultant Radiologist, Nuclear Medicine, East and North Hertfordshire NHS Trust
Artefacts in PET
Dr Bal Sanghera, Clinical Scientist, Paul Strickland Scanner Centre
How long is long enough for a PET Scanner?
Professor Rodney Hicks, Professor of Nuclear Medicine, Precision Molecular Imaging and Theranostics
Panel discussion
Advanced accelerator applications: Innovating against cancer – sponsored video
Session 2: PSMA imaging and therapy
Chair: Professor Vineet Prakash, Radiology and Nuclear Medicine Consultant, Royal Surrey County Hospital
Diagnostics for Lu PSMA
Professor Gary Cook, Professor of PET imaging, King’s College London
Setting up a Lu PSMA service
Professor Vineet Prakash, Radiology and Nuclear Medicine Consultant, Royal Surrey County Hospital and Dr James Scuffham, Medical Physics, Royal Surrey County Hospitals
PSMA therapy- game-changer or in need of a changed game-plan?
Professor Rodney Hicks
Panel discussion
Lunch
Session 3: New roles for PET-CT
Chair: Professor Richard Graham, Radiology Consultant, Royal United Hospitals Bath
FDG PET/CT and novel molecular imaging for directing immunotherapy in cancer
Dr Manil Subesinghe, Radiology Consultant, Guy’s and St Thomas’ NHS Foundation Trust
PET in gynaecology and oligometastatic breast cancer
Professor Lioe-Fee de Geus-Oei, Professor in Radiology, Leiden University Medical Center
Panel discussion
Session 4: The informed reporter
Chair: Dr Thomas Wagner, Nuclear Medicine Consultant, Royal Free London NHS Foundation Trust
PET-CT and cardiac infection
Dr Tamir Ali, Radiology Consultant, Newcastle Upon Tyne Hospitals NHS Foundation Trust
PET CT applications in rheumatological disorders an update
Professor Roland Hustinx, Professor of Nuclear Medicine, Liege University Hospital
Parathyroid PET imaging
Dr Dilip Patel, Radiology Consultant, Royal Infirmary of Edinburgh
Panel discussion
Session 5: Horizon scanning I: Emerging tracers for PET
Chair: Dr George Petrides, Radiology Consultant, Newcastle Upon Tyne Hospitals
89Zr CD8 ImmunoPET and its uses
Michael Ferris, Associate Director, ImaginAb Europe
Preclinical sarcoma antibody tracer development
Dr James Knight, Lecturer in Radiochemistry, Newcastle University
Emerging tracers in Italy
Paolo Castellucci, Nuclear Medicine Physician, University of Bologna
Panel discussion
Close of day one
Day 2
Welcome and introduction
Session 1: PET CT, molecular therapy services and NHSE
Dr Wai Lup Wong, Consultant Radiologist Nuclear Medicine, East and North Hertfordshire NHS Trust
Integrated care boards and specialised services, cancer ambitions and the NHS long term plan
Nicola McCulloch, Head of the Cancer Programme of Care - Specialised Commissioning, NHS England
An introduction to the NCRI CT Rad group and the UK MRT consortium
Professor Jon Wadsley, Consultant Clinical Oncologist, Sheffield Teaching Hospitals NHS Foundation trust and Dr Darren Leaning, Consultant Clinical Oncologist, South Tees Hospitals NHS Foundation Trust
Emerging molecular therapies
Professor Peter Hoskin, Professor of Clinical Oncology, University of Manchester
Panel discussion
Advanced accelerator applications: Innovating against cancer – sponsored video
Session 2: PET-CT around the globe
Chair: Dr Amy Eccles, Consultant in Radiology/Nuclear Medicine, Imperial College Healthcare NHS Trust
PET-CT in Singapore
Professor Sean X Yan, Senior Consultant, Singapore General Hospital and Associate Professor, Duke-Nus Medical School
PET-CT in South Africa
Professor Mike Sathekge, Professor and Head of Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital of Pretoria
Emerging tracer in the UK - An introduction to F-CETO imaging
Professor Franklin Aigbirhio, Professor of Molecular Imaging Chemistry, University of Cambridge
Panel discussion
Lunch
Session 3: Evolving uses of PET-CT
Chair: Dr Chirag Patel, Radiology Consultant, Leeds Teaching Hospitals
Use of PET with novel lymphoma treatments
Dr Wendy Osborne, Consultant Haematologist, Newcastle Upon Tyne Hospitals and Dr George Petrides, Consultant Radiologist, Newcastle Upon Tyne Hospitals
CAR-T therapy and PET-CT
Dr Nicola Mulholland, Consultant Radiologist and Nuclear Medicine Physician, King's College Hospitals NHS Foundation Trust
Fluoride PET in the cardiovascular system
Dr Michelle Williams, Consultant Radiologist and Senior Clinical Lecturer, University of Edinburgh
Panel discussion
Session 4: The informed reporter
Dr Tamir Ali, Radiology Consultant, Newcastle Upon Tyne Hospitals
FDG PET-CT for lung cancer
Dr Thomas Wagner, Nuclear Medicine Consultant, Royal Free London NHS Foundation Trust
PET CT in paediatrics
Dr Claire Gowdy, Consultant in Paediatric Nuclear Medicine, University of British Columbia
RECIST v1.1 pearls and pitfalls
Dr Amish Lakhani, Consultant Radiologist, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre and Imperial College Healthcare NHS Trust
Panel discussion
Session 5: Horizon scanning II: Radiomics and AI in PET
Chair: Dr George Petrides,Radiology Consultant, Newcastle Upon Tyne Hospitals
Artificial Intelligence in lymphoma
Professor Andy Scarsbrook, Consultant Radiologist and Nuclear Medicine Physician, Leeds Teaching Hospitals NHS Trust
An introduction to radiomics in PET and oesophageal cancer
Nick Vennart, Nuclear Medicine Physics Lead, South Tyneside and Sunderland NHS Foundation Trust
Panel discussion
Close of meeting
Sponsors
Location
Online
Registration for this event will close at 7:00am on Monday 20 March 2023. Late registrations will not be accepted.
The agenda is subject to change at any time.
We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.